Potential benefits of immunomodulator use with vedolizumab for maintenance of remission in ulcerative colitis.
Naganuma M, Watanabe K, Motoya S, Ogata H, Matsui T, Suzuki Y, Ursos L, Sakamoto S, Shikamura M, Hori T, Fernandez J, Watanabe M, Hibi T, Kanai T.
Naganuma M, et al. Among authors: sakamoto s.
J Gastroenterol Hepatol. 2022 Jan;37(1):81-88. doi: 10.1111/jgh.15667. Epub 2021 Sep 7.
J Gastroenterol Hepatol. 2022.
PMID: 34409654
Free PMC article.